Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04LDK
|
|||
Former ID |
DIB016723
|
|||
Drug Name |
TZP-202
|
|||
Indication | Dyspepsia [ICD-11: MD92; ICD-9: 536.8] | Preclinical | [1] | |
Company |
Tranzyme Pharma Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Motilin receptor (MLNR) | Target Info | Antagonist | [2] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Peptide ligand-binding receptors | |||
G alpha (q) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023009) | |||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023009) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.